• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

因子 XIIa 通过与纤维蛋白的直接相互作用,独立于凝血酶生成调节纤维蛋白凝块的结构。

Factor XIIa regulates the structure of the fibrin clot independently of thrombin generation through direct interaction with fibrin.

机构信息

Laboratory for Clinical Thrombosis and Haemostasis, Department of Internal Medicine, Cardiovascular Research Institute Maastricht, Maastricht University Medical Center, Maastricht, The Netherlands.

出版信息

Blood. 2011 Oct 6;118(14):3942-51. doi: 10.1182/blood-2011-03-339572. Epub 2011 Aug 9.

DOI:10.1182/blood-2011-03-339572
PMID:21828145
Abstract

Recent data indicate an important contribution of coagulation factor (F)XII to in vivo thrombus formation. Because fibrin structure plays a key role in clot stability and thrombosis, we hypothesized that FXII(a) interacts with fibrin(ogen) and thereby regulates clot structure and function. In plasma and purified system, we observed a dose-dependent increase in fibrin fiber density and decrease in turbidity, reflecting a denser structure, and a nonlinear increase in clot stiffness with FXIIa. In plasma, this increase was partly independent of thrombin generation, as shown in clots made in prothrombin-deficient plasma initiated with snake venom enzyme and in clots made from plasma deficient in FXII and prothrombin. Purified FXII and α-FXIIa, but not β-FXIIa, bound to purified fibrinogen and fibrin with nanomolar affinity. Immunostaining of human carotid artery thrombi showed that FXII colocalized with areas of dense fibrin deposition, providing evidence for the in vivo modulation of fibrin structure by FXIIa. These data demonstrate that FXIIa modulates fibrin clot structure independently of thrombin generation through direct binding of the N-terminus of FXIIa to fibrin(ogen). Modification of fibrin structure by FXIIa represents a novel physiologic role for the contact pathway that may contribute to the pathophysiology of thrombosis.

摘要

最近的数据表明凝血因子(F)XII 对体内血栓形成有重要贡献。由于纤维蛋白结构在血栓稳定性和血栓形成中起着关键作用,我们假设 FXII(a)与纤维蛋白(原)相互作用,从而调节血栓结构和功能。在血浆和纯化系统中,我们观察到纤维蛋白纤维密度呈剂量依赖性增加,浊度降低,反映出结构更加致密,FXIIa 使血栓的硬度呈非线性增加。在血浆中,这种增加部分独立于凝血酶生成,如在缺乏凝血酶原的血浆中用蛇毒酶启动制成的血栓和缺乏 FXII 和凝血酶原的血浆制成的血栓中所示。纯化的 FXII 和 α-FXIIa,但不是 β-FXIIa,与纯化的纤维蛋白原和纤维蛋白以纳摩尔亲和力结合。对人颈动脉血栓的免疫染色显示,FXII 与纤维蛋白沉积密集区共定位,为 FXIIa 在体内调节纤维蛋白结构提供了证据。这些数据表明,FXIIa 通过 FXIIa 的 N 端与纤维蛋白(原)的直接结合,独立于凝血酶生成来调节纤维蛋白凝块结构。FXIIa 对纤维蛋白结构的修饰代表了接触途径的一个新的生理作用,可能有助于血栓形成的病理生理学。

相似文献

1
Factor XIIa regulates the structure of the fibrin clot independently of thrombin generation through direct interaction with fibrin.因子 XIIa 通过与纤维蛋白的直接相互作用,独立于凝血酶生成调节纤维蛋白凝块的结构。
Blood. 2011 Oct 6;118(14):3942-51. doi: 10.1182/blood-2011-03-339572. Epub 2011 Aug 9.
2
The role of activated coagulation factor XII in overall clot stability and fibrinolysis.活化凝血因子 XII 在整体血栓稳定性和纤维蛋白溶解中的作用。
Thromb Res. 2015 Aug;136(2):474-80. doi: 10.1016/j.thromres.2015.06.028. Epub 2015 Jun 19.
3
Inhibiting the intrinsic pathway of coagulation with a factor XII-targeting RNA aptamer.用一种靶向因子 XII 的 RNA 适体抑制凝血的内源性途径。
J Thromb Haemost. 2013 Jul;11(7):1364-73. doi: 10.1111/jth.12302.
4
Factor XII promotes blood coagulation independent of factor XI in the presence of long-chain polyphosphates.在长链多聚磷酸盐存在的情况下,因子 XII 可促进血液凝结,而无需因子 XI 的参与。
J Thromb Haemost. 2013 Jul;11(7):1341-52. doi: 10.1111/jth.12295.
5
Factor XII regulates the pathological process of thrombus formation on ruptured plaques.因子 XII 调节破裂斑块上血栓形成的病理过程。
Arterioscler Thromb Vasc Biol. 2014 Aug;34(8):1674-80. doi: 10.1161/ATVBAHA.114.303315. Epub 2014 May 22.
6
Factor XII inhibition reduces thrombus formation in a primate thrombosis model.十二因子抑制减少灵长类动物血栓模型中的血栓形成。
Blood. 2014 Mar 13;123(11):1739-46. doi: 10.1182/blood-2013-04-499111. Epub 2014 Jan 9.
7
Identification of the histidine-rich glycoprotein domains responsible for contact pathway inhibition.负责接触途径抑制的富含组氨酸糖蛋白结构域的鉴定。
J Thromb Haemost. 2022 Apr;20(4):821-832. doi: 10.1111/jth.15631. Epub 2022 Jan 14.
8
Establishing the Transient Mass Balance of Thrombosis: From Tissue Factor to Thrombin to Fibrin Under Venous Flow.建立血栓的瞬态质量平衡:从组织因子到凝血酶到静脉血流下的纤维蛋白。
Arterioscler Thromb Vasc Biol. 2018 Jul;38(7):1528-1536. doi: 10.1161/ATVBAHA.118.310906. Epub 2018 May 3.
9
Cellular procoagulant activity dictates clot structure and stability as a function of distance from the cell surface.细胞促凝活性决定了凝块结构和稳定性,这是细胞表面距离的函数。
Arterioscler Thromb Vasc Biol. 2008 Dec;28(12):2247-54. doi: 10.1161/ATVBAHA.108.176008. Epub 2008 Oct 30.
10
Differential binding of factor XII and activated factor XII to soluble and immobilized fibronectin--localization of the Hep-1/Fib-1 binding site for activated factor XII.凝血因子 XII 及活化凝血因子 XII 与可溶性和固定化纤连蛋白的差异结合——活化凝血因子 XII 的 Hep-1/Fib-1 结合位点的定位
FEBS J. 2008 Oct;275(20):5161-72. doi: 10.1111/j.1742-4658.2008.06647.x. Epub 2008 Sep 11.

引用本文的文献

1
Advancements in research on the thrombo-inflammation mechanisms mediated by factor XII in ischemic stroke.缺血性卒中中由因子XII介导的血栓形成-炎症机制的研究进展。
J Thromb Thrombolysis. 2025 Apr 26. doi: 10.1007/s11239-025-03101-6.
2
Protofibril packing density of individual fibers alters fibrinolysis.单个纤维的原纤维堆积密度会改变纤维蛋白溶解。
Res Pract Thromb Haemost. 2025 Feb 28;9(2):102708. doi: 10.1016/j.rpth.2025.102708. eCollection 2025 Feb.
3
High-dose fish oil supplements are more effective than oily fish in altering the number and function of extracellular vesicles in healthy human subjects: a randomised, double-blind, placebo-controlled, parallel trial.
高剂量鱼油补充剂在改变健康人体细胞外囊泡的数量和功能方面比油性鱼类更有效:一项随机、双盲、安慰剂对照的平行试验。
Br J Nutr. 2025 Mar 21;133(7):1-11. doi: 10.1017/S0007114525000625.
4
Arterial Thrombosis in Acute Respiratory Infections: An Underestimated but Clinically Relevant Problem.急性呼吸道感染中的动脉血栓形成:一个被低估但具有临床相关性的问题。
J Clin Med. 2024 Oct 9;13(19):6007. doi: 10.3390/jcm13196007.
5
Identification of oxylipins and lipid mediators in pulmonary embolism.肺栓塞中氧化脂质和脂质介质的鉴定。
Lipids Health Dis. 2024 Oct 9;23(1):330. doi: 10.1186/s12944-024-02315-6.
6
Biomechanics, Energetics, and Structural Basis of Rupture of Fibrin Networks.纤维蛋白网络破裂的生物力学、能量学和结构基础。
Adv Healthc Mater. 2023 Oct;12(27):e2300096. doi: 10.1002/adhm.202300096. Epub 2023 Aug 31.
7
Factor XII contributes to thrombotic complications and vaso-occlusion in sickle cell disease.因子 XII 有助于镰状细胞病中的血栓并发症和血管闭塞。
Blood. 2023 Apr 13;141(15):1871-1883. doi: 10.1182/blood.2022017074.
8
Mechanisms for Reduced Fibrin Clot Formation on Liquid-Infused Surfaces.液体浸润表面减少纤维蛋白凝块形成的机制。
Adv Healthc Mater. 2022 Nov;11(21):e2201360. doi: 10.1002/adhm.202201360. Epub 2022 Sep 9.
9
Fibrin protofibril packing and clot stability are enhanced by extended knob-hole interactions and catch-slip bonds.纤维蛋白原纤维的包装和血栓稳定性通过扩展的扣眼相互作用和捕获-滑动键增强。
Blood Adv. 2022 Jul 12;6(13):4015-4027. doi: 10.1182/bloodadvances.2022006977.
10
Altered fibrin clot structure and dysregulated fibrinolysis contribute to thrombosis risk in severe COVID-19.纤维蛋白凝块结构改变和纤溶失调导致严重 COVID-19 血栓形成风险增加。
Blood Adv. 2022 Feb 8;6(3):1074-1087. doi: 10.1182/bloodadvances.2021004816.